TY - JOUR
T1 - Evaluation of Clinical Performance of Ponto Implantation Using a Minimally Invasive Surgical Technique
T2 - A Prospective Multicenter Study
AU - Teunissen, Emma M.
AU - Aukema, Tjerk W.
AU - Banga, Rupan
AU - Eeg-Olofsson, Måns
AU - Hol, Myrthe K.S.
AU - Hougaard, Dan D.
AU - Tysome, James R.
AU - Johansson, Martin L.
AU - Svensson, Sara
AU - Powell, Harry R.F.
N1 - Publisher Copyright:
Copyright © 2024 The Author(s).
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Objective: To investigate the clinical outcomes of bone-anchored hearing implant surgery using the MONO procedure. Study Design: Multicenter, multinational, single-arm, prospective trial with a 12-month follow-up. Setting: Seven European university hospitals from the United Kingdom, Sweden, Denmark, and The Netherlands. Patients: Fifty-one adult patients requiring surgical intervention for bone conduction hearing. Intervention: Bone-anchored hearing implant surgery using the MONO procedure. Main Outcome Measures: The primary endpoint assessed implant usability 3 months after surgery. Implant status, soft tissue reactions, pain and numbness, postoperative events, and sound processor usage were assessed at all follow-up visits. Hearing-related quality of life was evaluated using the Glasgow Benefit Inventory (GBI). Results: At 3 months, 94.2% of the implant/abutment complexes provided reliable anchorage for sound processor usage. No severe intraoperative complications occurred. Sixty-nine percent of surgeries were performed under local anesthesia, with surgery lasting 10 minutes on average. Four implants were lost due to trauma (n = 2), spontaneous loss of osseointegration (n = 1), or incomplete insertion (n = 1). Adverse soft tissue reactions occurred in 2.6% of visits, with a maximum Holgers grade of 3 (n = 1) and grade 2 (n = 5) across patients. Hearing-related quality of life at 3 months improved in 96% of patients. Conclusion: The MONO procedure provides a safe and efficient surgical technique for inserting bone-anchored hearing implants with few and minor intra- and postoperative complications.
AB - Objective: To investigate the clinical outcomes of bone-anchored hearing implant surgery using the MONO procedure. Study Design: Multicenter, multinational, single-arm, prospective trial with a 12-month follow-up. Setting: Seven European university hospitals from the United Kingdom, Sweden, Denmark, and The Netherlands. Patients: Fifty-one adult patients requiring surgical intervention for bone conduction hearing. Intervention: Bone-anchored hearing implant surgery using the MONO procedure. Main Outcome Measures: The primary endpoint assessed implant usability 3 months after surgery. Implant status, soft tissue reactions, pain and numbness, postoperative events, and sound processor usage were assessed at all follow-up visits. Hearing-related quality of life was evaluated using the Glasgow Benefit Inventory (GBI). Results: At 3 months, 94.2% of the implant/abutment complexes provided reliable anchorage for sound processor usage. No severe intraoperative complications occurred. Sixty-nine percent of surgeries were performed under local anesthesia, with surgery lasting 10 minutes on average. Four implants were lost due to trauma (n = 2), spontaneous loss of osseointegration (n = 1), or incomplete insertion (n = 1). Adverse soft tissue reactions occurred in 2.6% of visits, with a maximum Holgers grade of 3 (n = 1) and grade 2 (n = 5) across patients. Hearing-related quality of life at 3 months improved in 96% of patients. Conclusion: The MONO procedure provides a safe and efficient surgical technique for inserting bone-anchored hearing implants with few and minor intra- and postoperative complications.
KW - BAHA
KW - BAHI
KW - Bone conduction
KW - Bone-anchored hearing aid
KW - Bone-anchored hearing implant
KW - Implant loss
KW - Minimal invasive
KW - MONO
KW - Soft tissue reactions
UR - http://www.scopus.com/inward/record.url?scp=85202843806&partnerID=8YFLogxK
U2 - 10.1097/MAO.0000000000004315
DO - 10.1097/MAO.0000000000004315
M3 - Article
C2 - 39186326
AN - SCOPUS:85202843806
SN - 1531-7129
VL - 45
SP - 1037
EP - 1044
JO - Otology and Neurotology
JF - Otology and Neurotology
IS - 9
ER -